SP

Shanavas Panayamkandy

Director Director DIN 09753244
DIN 09753244 First appointment Aug 2022 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 2022
Shareholding value Locked Premium profile

About Shanavas Panayamkandy

Data last updated:

Shanavas Panayamkandy has 4 years in corporate governance. Formerly with 1 company, such as Remex Medical Centre Llp. Engaged in General Business. Contributes to corporate operations.

DIN 09753244
Primary Designation Director
First Appointment 19 Aug 2022
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Designated Partner19 Aug 20222021Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Remex Medical Centre Llp
Premium access

Shareholding and investment profile for Shanavas Panayamkandy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shanavas Panayamkandy

Shanavas Panayamkandy has 4 years in corporate governance. Formerly with 1 company, such as Remex Medical Centre Llp. Engaged in General Business. Contributes to corporate operations.

Shanavas Panayamkandy is associated with 0 companies as a director.

Shanavas Panayamkandy has expertise in General Business.

Shanavas Panayamkandy has 4 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available